David Abrams
Abrams Capital Management
Abrams Capital Management Portfolio 13F
David Abrams Holdings Activity
- Portfolio value:
- $3.22B≈ (+$191M≈)
- Previous value:
- $3.03B≈
- # of changes:
- 3
- New positions:
- 0
- Reported for:
- 31 Dec 2023 (Q4)
- Latest filing date:
- 09 Feb 2024
Abrams Capital Management has disclosed a total of 3 changes to the portfolio in the (2023 Q4) SEC report(s): decreased the number of shares of 3 position(s).
What stocks did David Abrams buy in 2023 Q4?
During 2023 Q4 David Abrams has not purchased any securities.
In the 2023 Q4 report(s) the following change has been made to the top investments: (META) Meta Platforms Inc (reduced shares -23.36%).
3 results
| History | Ticker | Name |
% or activity |
Shares change |
Shares held after* |
% change to portfolio |
Reported price* |
% difference current price* |
% of portfolio |
Held since* | Held for* |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
Meta Platforms Inc
|
-23.36%
|
-216,924
|
711,550
|
-2.54%
|
$353.96
|
+55.16%($549.19)
|
7.83%
|
2018 Q4
|
≈ 5.25 years
|
|
|
|
Teva Pharma Industries Ltd ADR
|
-24.72%
|
-1,969,597
|
5,996,836
|
-0.68%
|
$10.44
|
+235.73%($35.05)
|
1.95%
|
2017 Q3
|
≈ 6.50 years
|
|
|
|
US Century Bank
|
-76.92%
|
-499,299
|
149,786
|
-0.2%
|
$12.25
|
+77.27%($21.72)
|
0.06%
|
2021 Q3
|
≈ 2.50 years
|
|
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
* Current price: this can be a delayed price and may not reflect the real-time market value, however it is too close.
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* Held since / Held for: calculated since the latest "new buy" position. If the security was previously exited and re-entered, only the most recent holding period is counted.